MinichMacGregor Wealth Management LLC Buys New Position in First Trust Nasdaq Pharmaceuticals ETF $FTXH

MinichMacGregor Wealth Management LLC acquired a new position in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 23,337 shares of the company’s stock, valued at approximately $968,000. MinichMacGregor Wealth Management LLC owned approximately 0.09% of First Trust Nasdaq Pharmaceuticals ETF at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in FTXH. Nilsine Partners LLC lifted its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 3.5% during the second quarter. Nilsine Partners LLC now owns 28,057 shares of the company’s stock worth $1,071,000 after purchasing an additional 937 shares during the period. Compass Financial Management LLC purchased a new position in shares of First Trust Nasdaq Pharmaceuticals ETF during the 2nd quarter valued at about $29,000. Finally, Vivaldi Capital Management LP lifted its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 16.0% in the 1st quarter. Vivaldi Capital Management LP now owns 12,590 shares of the company’s stock valued at $433,000 after buying an additional 1,741 shares during the period.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

NASDAQ:FTXH traded up $0.85 during trading hours on Wednesday, reaching $41.28. The company had a trading volume of 20,488 shares, compared to its average volume of 233,446. First Trust Nasdaq Pharmaceuticals ETF has a 1-year low of $28.85 and a 1-year high of $43.52. The firm has a market cap of $1.07 billion, a PE ratio of 14.51 and a beta of 0.45. The business’s 50 day moving average price is $41.07 and its 200-day moving average price is $37.70.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Thursday, September 24th were issued a $0.0113 dividend. This represents a $0.05 annualized dividend and a yield of 0.1%. The ex-dividend date was Thursday, September 24th. This is a negative change from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.0920.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.